Rajkumar Ganesan, PhDExecutive Director, Oncology Research at Amgen
Currently, an Executive Director at Amgen and oversee preclinical discovery efforts for immunotherapeutics. I received my PhD in Molecular Biology / Biochemistry from University of Zurich. Over the last 15+ years, while working for Genentech, AstraZeneca, Boehringer Ingelheim, Janssen, my team and I led the discovery efforts for molecular and cellular therapies and progressed series of Biotherapeutics and CAR-Ts for clinical development. Notable accomplishments include discovery of SPEVIGO® (Spesolimab) and pre-clinical discovery of multiple T cell engagers for hematological malignancies and solid tumors. I’m passionate about the emerging approaches for the design and development of next-generation T cell engagers.